Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-89
SponsorUniversity of Alabama at Birmingham

About this trial

The goal of this clinical trial is to learn if extended admission to the Kangaroo Mother Care (KMC) ward helps to prevent postpartum depression in mothers of low birthweight infants in a low-resource setting whose newborns were admitted to the neonatal intensive care unit (NICU) more than standard of care KMC. The main questions it aims to answer are:

* Does longer KMC decrease the incidence of postpartum depression in mothers of low birthweight infants in a low-resource setting? * Does longer KMC improve neurodevelopmental outcomes of low birthweight infants at 6, 12, and 18 months in a low-resource setting? * What are the barriers to practicing KMC in low birthweight infants following hospital discharge in a low-resource setting? * What is the prevalence of paternal depression in a low resource setting? * Is it cost effective to admit preterm mother-infant dyads to the KMC ward following NICU discharge?

Researchers will compare (extended admission to the KMC ward) to (standard of care KMC) to see if extended KMC decreases PPD in mothers of preterm infants in low-resource settings.

Participants (infants) will:

* At time of discharge from the NICU, when clinically stable, spend either \< 2 days in the KMC ward with their mothers or spend longer in the KMC ward until discharge. * Return to clinic at routine follow-up visits (at 2 weeks and at 6-8 weeks) where mothers will be screened for postpartum depression and fathers will be screened for depression. * Return to clinic for neurodevelopmental screening at 6, 12, and 18 months where mothers will be screened for postpartum depression and perceived social support and fathers will be screened for depression.

Eligibility criteria

Qualifiers

AIM #3

Parents (mothers and fathers) whose newborn has been enrolled in the study

Trusted family member or friend of the mother whose newborns is enrolled into the study

16+ years of age (mothers and fathers)

Disqualifiers

AIM #1-2 and #5

Mothers who are on treatment for depression and/or anxiety

Mothers who did not consent

Underage mothers (16-17 years of age) whose parent(s) has not provided consent for their participation in the study

Trial design

Treatments tested in this trial

  • Kangaroo mother care (KMC) support for > 2 days
  • Kangaroo mother care (KMC) support for < 2 days

Treatment groups

1,908 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor

University Teaching Hospital, Lusaka, Zambia

Collaborator

University of Zambia

Collaborator

University of Cincinnati

Collaborator

Centre for Infectious Disease Research in Zambia

Collaborator